Co-founder of The New Face of Recovery™ uses personal experience to challenge the idea that dependency is an incurable brain disease. (PRWeb Dec 31, 2009)
Read the flooded story at http://www.prweb.com/releases/addiction/recovery/prweb3391314.htm
PharmaSmart International, Inc., an award winning Inc. 5000 company and "Top 100" Rochester, NY Growth Company, is partnering with AstraZeneca Canada to deliver innovative tools and programs to pharmacists, physicians and patients for the improved management of hypertension. The partnership program positions community pharmacy at the front lines of disease state management, and will involve a select group of Canadian retail pharmacy participants. (PRWeb Dec 30, 2009)
Read the full story at http://www.prweb.com/releases/PharmaSmart/AstraZeneca_Canada/prweb3392894.htm
Caffeine is known for its ability to wake up your mind, but it crapper also wake up your skin when combined with Capsaicin, the active ingredient in hot peppers. Capsaicin has been proven as an important natural medicine that relieves pain, inflammation, headaches and more, but now there’s a new buzz surrounding the anti-aging properties of this spicy botanical extract. While large doses of capsaicin are proven to fight pain and inflammation, it turns out that small doses crapper be used to repair skin when combined with caffeine, and there’s no burning sensation. (PRWeb Dec 24, 2009)
Read the full story at http://www.prweb.com/releases/2009/12/prweb3382724.htm
Medavera, Inc., a continuing medical education provider, today announced the appointment of a new leader who will help expand its offerings of novel, engaging scientifically based education. (PRWeb Dec 23, 2009)
Read the full story at http://www.prweb.com/releases/Continuing/Medical_Education/prweb3378644.htm
Program rewards eligible physicians meeting quality standards. Open to primary care doctors who agree to BCBSNC’s standard contract. Physicians may qualify for double-digit increases in reimbursement for commonly billed services (PRWeb Dec 18, 2009)
Read the full story at http://www.prweb.com/releases/BCBSNC/Quality-Physician-Program/prweb3359544.htm
PricewaterhouseCoopers’ Health Research Institute's Top 10 Health Industry Issues in 2010, puts healthcare cost control at the head of the list as the overarching theme for the year ahead. (PRWeb Dec 17, 2009)
Read the full news at http://www.prweb.com/releases/pwc/health-industry-issues/prweb3357594.htm
Looking for the ultimate CHO cell culture supplement? InVitria has what scientists have been asking for! Zap-CHO is a robust CHO cell culture media supplement that improves the growth and productivity of CHO cells. Developed for scientists seeking maximum CHO cell culture performance, Zap-CHO is an animal free, well defined and consistent recombinant CHO supplement. (PRWeb Dec 16, 2009)
Read the full story at http://www.prweb.com/releases/InVitriaZapCHOvideo/CHOcellculture/prweb3350724.htm
The National Eye Institute (NEI), a division of the National Institutes of Health (NIH), awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis. (PRWeb Dec 10, 2009)
Read the full story at http://www.prweb.com/releases/2009/12/prweb3313064.htm
It's again that time of year, which brings hope, love, jingle bells and people together. Rxonlinetoday is also celebrating the spirit of holidays by announcing discounted prices on all pain relieving drugs with tramadol being most popular of all. (PRWeb Dec 9, 2009)
Read the full story at http://www.prweb.com/releases/rxonlinetoday/buy-tramadol-at-70-usd/prweb3311044.htm
Canadian dental practice adopts latest digital signage technology to educate patients on site (PRWeb Dec 8, 2009)
Read the full story at http://www.prweb.com/releases/2009/12/prweb3294414.htm
Nutra Pharma has completed submission of the final Nyloxin OTC and Nyloxin Rx packaging and labeling to the Food and Drug Administration (FDA). This registration is considered the final step required by the FDA to begin selling Nyloxin OTC and Nyloxin Rx in the United States for the treatment of chronic pain. (PRWeb Dec 7, 2009)
Read the full story at http://www.prweb.com/releases/NutraPharma/Nyloxin/prweb3304624.htm
Nutra Pharma will be conducting a webinar on December 10, 2009, to discuss the Company’s over-the-counter and prescription treatments for chronic pain, Cobroxin and Nyloxin Rx. (PRWeb Dec 4, 2009)
Read the full story at http://www.prweb.com/releases/Nutra_Pharma/chronic_pain/prweb3292834.htm
Recent studies have shown that breast cancer drugs such as tamoxifen and raloxifene increase chance of other breast cancers and blood clots, yet travel daily offers better preventative rates without the risk of side effects. (PRWeb Dec 2, 2009)
Read the full story at http://www.prweb.com/releases/treadmill_desk/breast_cancer/prweb3286574.htm
Anthony M. Marlon, MD was elected to the Stemedica Cell Technologies, Inc. (“Stemedica”) Board of Directors at the Company’s November 20th Board Meeting. (PRWeb Dec 1, 2009)
Read the full story at http://www.prweb.com/releases/stemedica-board/anthony-marlon/prweb3281184.htm